Blood transfusions were deadly gambles until one doctor mixed red cells
For centuries, blood transfusions were catastrophic rolls of the dice: patients occasionally survived, but many suffered violent reactions and died. In 1900, Austrian physician Karl Landsteiner tested blood serum against red cells from his colleagues and noticed they sometimes clumped together into toxic clumps. This observation revealed distinct blood types—later classified as A, B, AB, and O—revolutionizing medicine, making surgeries and transfusions safe, and earning Landsteiner a Nobel Prize.
The Perilous Gamble of Early Transfusions
For centuries, the idea of infusing blood from a healthy donor into a dying patient appeared to be a straightforward remedy for severe hemorrhage and debilitating illness. Yet in practice, blood transfusions were notoriously unpredictable and frequently fatal. Early medical pioneers attempted transfusions using both animal blood and blood from human volunteers, but the outcomes seemed entirely governed by chance. While an occasional recipient experienced a miraculous recovery, many others suffered violent chills, fever, dark urine, shock, and rapid death. These disastrous episodes led several medical authorities and governing bodies across Europe to ban the procedure altogether.
By the late nineteenth century, pathologists recognized that incompatible blood transfusions triggered the clumping and destruction of red blood cells, a process known as agglutination and hemolysis. However, researchers widely assumed that this destructive reaction was caused by disease, infection, or fundamental biological differences between animal and human blood. The scientific consensus held that blood from healthy human beings was functionally identical from one person to the next. Because scientists could not explain why transfusing blood between two seemingly healthy individuals sometimes succeeded and sometimes proved lethal, the procedure remained a desperate, last-resort gamble.
Landsteiner's Laboratory Experiment
The breakthrough came in Vienna at the turn of the twentieth century through the work of Karl Landsteiner. Born in Vienna in 1868, Landsteiner had studied medicine at the University of Vienna before spending years training in organic chemistry under leading European scientists, including Emil Fischer in Würzburg, Eugen Bamberger in Munich, and Arthur Hantzsch in Zurich. This rigorous foundation in chemical principles gave Landsteiner a unique perspective when he returned to Vienna to work as an assistant under Anton Weichselbaum at the Pathological-Anatomical Institute, where he turned his attention to serology and the behavior of blood serum.